Premium
Clinical studies with agents active on the 5‐lipoxygenase pathway
Author(s) -
Drazen Jeffrey
Publication year - 1995
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.1995.tb02731.x
Subject(s) - asthma , arachidonate 5 lipoxygenase , leukotriene , lipoxygenase , medicine , immunology , intensive care medicine , pharmacology , chemistry , enzyme , arachidonic acid , biochemistry
Leukotrienes may be considered asthmatic mediators. Compounds inhibiting their production and activity show promise in the treatment of asthma. Further clinical studies will determine the clinical usefulness of such agents.